Significant Ownership of Ansbert Gadicke

Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ansbert Gadicke.

Notify me when Ansbert Gadicke files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Ansbert Gadicke

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AKTSQ AKTIS ONCOLOGY, INC. Common Stock 19% $102,601 10,260,064 ANSBERT GADICKE 12 Jan 2026
HOWL WEREWOLF THERAPEUTICS, INC. Common Stock 6.9% $2,136,411 -$386,191 3,368,670 -15% ANSBERT GADICKE 14 Jan 2026
ITOS ITEOS THERAPEUTICS, INC. Common Stock 4.7% $10,192,577 1,803,996 ANSBERT GADICKE 13 May 2025
RPTX REPARE THERAPEUTICS INC. Common Shares 4.6% $1,941,242 -$208,173 1,941,242 -9.7% ANSBERT GADICKE 31 Jan 2025

Schedules 13D/G Reported by Ansbert Gadicke:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.